Current and emerging pharmacological therapy for non-alcoholic fatty liver disease.

Volume: 23, Issue: 42, Pages: 7495 - 7504
Published: Nov 14, 2017
Abstract
The main treatment of patients with non-alcoholic fatty liver disease (NAFLD) is life style modification including weight reduction and dietary regimen. Majority of patients are safely treated with this management and pharmacologic interventions are not recommended. However, a subgroup of NAFLD patients with non-alcoholic steatohepatitis (NASH) who cannot achieve goals of life style modification may need pharmacological therapy. One major...
Paper Details
Title
Current and emerging pharmacological therapy for non-alcoholic fatty liver disease.
Published Date
Nov 14, 2017
Volume
23
Issue
42
Pages
7495 - 7504
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.